SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-009731
Filing Date
2021-07-30
Accepted
2021-07-30 17:12:03
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20210630x10q.htm   iXBRL 10-Q 1186235
2 EX-31.1 imgn-20210630xex31d1.htm EX-31.1 10919
3 EX-31.2 imgn-20210630xex31d2.htm EX-31.2 10955
4 EX-32 imgn-20210630xex32.htm EX-32 10005
  Complete submission text file 0001558370-21-009731.txt   5657749

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20210630.xsd EX-101.SCH 45024
6 EX-101.CAL imgn-20210630_cal.xml EX-101.CAL 35841
7 EX-101.DEF imgn-20210630_def.xml EX-101.DEF 174266
8 EX-101.LAB imgn-20210630_lab.xml EX-101.LAB 440887
9 EX-101.PRE imgn-20210630_pre.xml EX-101.PRE 317900
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20210630x10q_htm.xml XML 962290
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 211133471
SIC: 2834 Pharmaceutical Preparations